Halima Buba, the Managing Director of SunTrust Bank Ltd., on Thursday, requested the Federal High Court in Abuja for permission to travel to the United States for urgent medical treatment due to complications related to her pregnancy. The request comes as Buba faces a six-count charge of money laundering.
In a motion filed by her lawyer, Senior Advocate of Nigeria (SAN) Johnson Usman, Buba asked the court to grant her leave to travel abroad for medical care and for the temporary release of her international passport. The motion, which was filed on February 3, 2026, outlined her need for expert medical attention at an international facility. Buba is currently under trial, along with Innocent Mbagwu, the Executive Director/Chief Compliance Officer of SunTrust, over an alleged $12 million fraud linked to the bank. The duo was arraigned on July 13, 2025, and each granted bail of N100 million with one surety.
Since the court’s order, Buba has complied with all bail conditions, including depositing her passport with the court’s registry. However, she now seeks to vary those conditions in light of her medical situation. In her motion, Buba emphasized that she has fully cooperated with the court proceedings and requested to travel to the U.S. from February 15 to the end of the month for specialized treatment.
Buba’s application, supported by an affidavit, outlines the nature of her pregnancy complications and the need for expert care at Bridge Clinics in Carmel, Indiana. According to the affidavit, local doctors at Deda Hospital in Abuja referred her to the U.S. specialists after discovering serious complications in her condition. She assured the court that she intends to return to Nigeria before the next trial session and has no intention of fleeing the country.
The Economic and Financial Crimes Commission (EFCC) opposed the request, accusing Buba of using medical reasons as a tactic to delay her trial. EFCC lawyer Ogechi Ujam filed a counter affidavit on February 3, arguing that Buba’s claims were speculative and unsupported by adequate medical evidence. Ujam contended that there was no indication that Buba could not receive appropriate care in Nigeria and that the hospitals listed in her affidavit did not confirm the need for international treatment.
Ujam further argued that the charges against Buba were serious, and given the progress of the trial, which has seen three key witnesses testify against her, there was a legitimate concern that Buba might evade the proceedings if allowed to travel abroad. The EFCC lawyer also criticized the trend of high-profile defendants in criminal cases seeking medical reasons to delay proceedings and potentially flee the country.
After hearing both sides, Justice Emeka Nwite adjourned the matter to March 4, 2026, for a ruling on Buba’s application. The court will decide whether to grant her the requested leave to travel for medical treatment or uphold the EFCC’s objections.

